Delivery Order SPE2DB20D3103-SPE2DB25FQ0A1
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,870.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM pharmaceutical product, valued at $2,424.17 under a firm fixed-price contract type. This non-set-aside award was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a child contract under a larger vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $2,288.33 delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ZORYVE is a topical dermatological treatment used primarily for inflammatory skin conditions, and this delivery order reflects...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ZORYVE 0.3% Foam 60GM, a topical dermatological medication. This firm fixed price delivery order, valued at $1,158.98, represents a non-set-aside competitive award with an ultimate completion date of August 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,263.17, is for the delivery of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This delivery order, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp on August 5, 2025, provides $1,113.09 in firm fixed price funding for ZORYVE 0.3% Foam 60gm, a pharmaceutical product to be delivered to the Conshohocken, Pennsylvania location with completion targeted for August 6, 2025. The award represents a non-competitive delivery order issued under an existing contract vehicle, reflecting DLA's established relationship with AmerisourceBergen as a critical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a ceiling value of $1,983.94 and a performance period extending through May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,457.92 to AmerisourceBergen Drug Corp for ZORYVE 0.15% Cream (60 grams) on August 25, 2025, with completion expected by August 26, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,384.83, is for the supply of the pharmaceutical product ZORYVE 0.3% FOAM 60GM. The contract has a firm fixed price pricing type and a period of performance through February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,800.64, is for the supply of ZORYVE 0.3% FOAM 60GM medical products. The contract is a Firm Fixed Price agreement with an ultimate completion date of November 7, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...